theoria-creative-logo-icon-dark

Scientific Communications

Scientific content and visual storytelling for publications, conferences, and external engagement.

Abstracts and Publications

Preparing an abstract, manuscript, or scientific article?
Structure the scientific narrative, clarify the findings, and develop figures and supporting visuals.

Conference Communications

Presenting data at a scientific or medical conference?
Create posters, presentations, data visuals, and supporting content with a defined information hierarchy.

Scientific Illustration and Visual Storytelling

Need a strong visual illustration for your science?
Develop mechanisms of action, pathway graphics, platform diagrams, scientific illustrations, and data visuals.

Examples of Work:

This slide from Lexeo Therapeutics' investor deck illustrates their strategy, highlighting programs in cardiac (Friedreich's Ataxia) and CNS (CLN2 Batten, APOE4 Alzheimer's) using intravenous and CNS administration of their AAVrh.10 platform.
An illustrative slide, for Enlivex Therapeutics' investor deck, detailing Allocetra™ as an off-the-shelf treatment to restore macrophage homeostasis. It outlines the process of collecting and modifying cells and the mechanism of action in a patient with inflammation.
his slide focuses on ALX148's potential in Myelodysplastic Syndromes (MDS). It shows the distribution of MDS cases at diagnosis based on risk stratification and the current available treatment paths for high-risk MDS patients, highlighting the unmet need in this area that ALX148 aims to address.
This graph presents data showing that Geographic Atrophy (GA) growth was notably reduced in patients who converted to wet Age-related Macular Degeneration (AMD) and were treated with APL-2. It compares the change in GA lesion size from baseline over time in a sham group versus two active groups receiving different APL-2 injection frequencies.
This scientific poster, for Diamedica Therapeutics, outlines the design of their randomized, double-blind, placebo-controlled adaptive study evaluating DM199 for the treatment of acute ischemic stroke (ReMEDy2 trial). It includes illustrations of brain arteries under different conditions (normal, ischemic, ischemic with DM199), the study design, population, endpoints, and analysis plan.
An abstract illustration representing interactions within the central nervous system, used by Myrobalan Therapeutics to visualize concepts like phagocytosis, synaptic pruning, immune activation, and re-myelination regulation.
This slide explains that cytokines are potent activators of the immune system but are challenging to deliver effectively due to systemic toxicities. It shows the systemic delivery of cytokines leading to inflammation in healthy tissues, highlighting the problem Werewolf Therapeutics aims to solve.
This illustration emphasizes the complex nature of neuropsychiatric disorders, showing how multiple susceptibility genes, epigenetic factors, and environmental factors interact, requiring a novel drug discovery approach, which Psychogenics aims to provide.
This slide from Q32 Bio illustrates their therapeutic approach to harness both the innate and adaptive immune responses. It shows a Venn diagram overlapping a human silhouette, with the left circle representing adaptive immunity and their ADX-914 targeting the IL-7/TSLP receptor, and the right circle representing innate immunity and their ADX-097 targeting Convertase. The central message highlights delivering novel therapeutics to achieve immune homeostasis in serious innate and adaptive immune system disorders.
This slide provides an overview of Spinal Cord Injury (SCI) as an incurable, lifelong condition. It illustrates types of SCI (tetraplegia and paraplegia), how SCI is characterized (exacerbated paralysis, neuropathic pain, spasticity), and emphasizes that even a small amount of recovery can make a huge difference in a patient's life.
This slide details Second Genome's proprietary 'SG platform,' emphasizing data standardization, geographic diversity, and strain level analysis. It showcases various tools and capabilities within the platform, including TracerMix, PhyloChip, StrainSelect, KnowledgeBase, MAGE, MTMA, RoleModel, MPE, Pantastic, and Helios, for comprehensive microbiome analysis and therapeutic discovery.
This slide illustrates the balance between immune tolerance and immune suppression in the liver and pancreas, explaining how the liver's natural tolerogenic environment can allow tumors to grow. This sets the stage for how Trisalus aims to unlock immunotherapy in these 'cold' solid tumors.

Work

Services

Presentations

We develop conceptual, graphics-driven corporate presentation materials for high-stakes meetings

Scientific Illustrations
We develop messaging, corporate story, content and graphics to ensure top quality of the final product – presentation deck.
Branding
We provide marketing design services to our existing customers.
Web design
We provide marketing design services to our existing customers.

About

Theoria creative
Our history, philosophy concept, team information
Oksana Bovt
Meet the founder Theoria Creative
Testimonials
Lorem ipsum dolor sit amet, consectetur dipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
FAQ
Lorem ipsum dolor sit amet, consectetur adipiscing elit